Diamines & Chemicals Limited has informed the Exchange regarding outcome of Board meeting held on February 12, 2026.
DIAMINESQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 2.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Diamines & Chemicals Limited approved Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended December 31, 2025. Standalone revenue from operations fell sharply to ₹763.37 lakhs in Q3 FY26 from ₹930.43 lakhs in Q3 FY25, and for the 9-month period dropped to ₹2,917.05 lakhs from ₹5,349.78 lakhs. Standalone profit after tax for Q3 plunged to just ₹11.90 lakhs (from ₹170.44 lakhs), and for the 9-month period slipped into a loss of ₹166.18 lakhs versus a profit of ₹429.24 lakhs last year. On a consolidated basis, 9-month PAT swung to a loss of ₹1,036.74 lakhs from a profit of ₹273.94 lakhs, pulled down by losses at subsidiary DACL Fine Chem and associate KU Organic Diamines. The statutory auditor K C Mehta & Co LLP issued an unqualified review report.
Shareholders should note a clear deterioration in performance — both top line and bottom line have contracted significantly, and the company has slipped into a loss on both standalone and consolidated 9-month bases. This is likely to weigh negatively on near-term sentiment, though results were reviewed without any audit qualifications.